- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 11.57M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 11.27K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.6K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $56K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.96M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.48M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $4.61M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $3.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.04M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $9.38M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.97M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.41M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.21M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $10.94M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $5.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $7.62M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.77M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.84M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.76M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.31 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $1.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.31 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.71M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.66M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $662K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $691K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.48M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.62M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.28M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.68M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $945K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $323K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $434K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $403K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.38M |
| Revenue | Q1 2026 · Mar 31, 2025 | $726K |